-
1
-
-
0033739530
-
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884
-
Fletcher CV, Acosta EP, Cheng H, et al. Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV-infected subjects: ACTG 884. AIDS 2000;14:2495-501.
-
(2000)
AIDS
, vol.14
, pp. 2495-2501
-
-
Fletcher, C.V.1
Acosta, E.P.2
Cheng, H.3
-
2
-
-
21544472342
-
Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: Results of AIDS clinical trials group 5108 study
-
Gerber JG, Rosenkranz SL, Fichtenbaum CJ, et al. Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS clinical trials group 5108 study. J Acquir Immune Defic Syndr 2005;39:307-12.
-
(2005)
J Acquir Immune Defic Syndr
, vol.39
, pp. 307-312
-
-
Gerber, J.G.1
Rosenkranz, S.L.2
Fichtenbaum, C.J.3
-
3
-
-
0033237706
-
Effect of indinavir on the single-dose pharmacokinetics of theophylline in healthy subjects
-
Mistry GC, Laurent A, Sterrett AT, Deutsch PJ. Effect of indinavir on the single-dose pharmacokinetics of theophylline in healthy subjects. J Clin Pharmacol 1999;39:636-42.
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 636-642
-
-
Mistry, G.C.1
Laurent, A.2
Sterrett, A.T.3
Deutsch, P.J.4
-
4
-
-
27844461529
-
Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: Final results of the EFADITE trial
-
Barrios A, Negredo E, Domingo P, et al. Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial. Antivir Ther 2005;10:825-32.
-
(2005)
Antivir Ther
, vol.10
, pp. 825-832
-
-
Barrios, A.1
Negredo, E.2
Domingo, P.3
-
5
-
-
34948889656
-
-
Kaul S, Bassi K, Damle B, et al. Pharmacokinetic evaluation of the combination of atazanavir, enteric coated didanosine, and tenofovir disoproxil fumarate for a once-daily antiretroviral regimen [abstract]. In: Program and abstracts of the 43rd interscience conference on antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology, 2003:abstract A-1616.
-
Kaul S, Bassi K, Damle B, et al. Pharmacokinetic evaluation of the combination of atazanavir, enteric coated didanosine, and tenofovir disoproxil fumarate for a once-daily antiretroviral regimen [abstract]. In: Program and abstracts of the 43rd interscience conference on antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology, 2003:abstract A-1616.
-
-
-
-
6
-
-
34948898449
-
-
Van Lunzen J, Schewe K, Kuhlmann B. High rate of virological failure during once-daily therapy with tenofovir + didanosine 250 mg + efavirenz in antiretroviral-naïve patients: results of the 12 week interim analysis of the TEDDI trial [abstract]. In: Program and abstracts of the 3rd International AIDS Society conference on HIV pathogenesis and treatment. Washington, DC: American Society for Microbiology, 2005:abstract TuPp0306.
-
Van Lunzen J, Schewe K, Kuhlmann B. High rate of virological failure during once-daily therapy with tenofovir + didanosine 250 mg + efavirenz in antiretroviral-naïve patients: results of the 12 week interim analysis of the TEDDI trial [abstract]. In: Program and abstracts of the 3rd International AIDS Society conference on HIV pathogenesis and treatment. Washington, DC: American Society for Microbiology, 2005:abstract TuPp0306.
-
-
-
-
7
-
-
20144365012
-
Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results
-
Kashuba AD, Tierney C, Downey GF, et al. Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results. AIDS 2005;19:145-52.
-
(2005)
AIDS
, vol.19
, pp. 145-152
-
-
Kashuba, A.D.1
Tierney, C.2
Downey, G.F.3
-
8
-
-
34948860470
-
-
Adkison K, Fang L, Shachoy-Clark A, et al. The pharmacokinetic inieraction between entry inhibitor 873140 and efavirenz in healthy adults [abstract]. In: Program and abstracts of the 45th interscience conference on antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology, 2005:abstract A-1197.
-
Adkison K, Fang L, Shachoy-Clark A, et al. The pharmacokinetic inieraction between entry inhibitor 873140 and efavirenz in healthy adults [abstract]. In: Program and abstracts of the 45th interscience conference on antimicrobial agents and chemotherapy. Washington, DC: American Society for Microbiology, 2005:abstract A-1197.
-
-
-
-
10
-
-
0027122957
-
revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
-
Centers for Disease Control and Prevention
-
Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
-
(1993)
MMWR Recomm Rep 1992
, vol.41
, pp. 1-19
-
-
-
11
-
-
34948847484
-
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents - October 6
-
United States Department of Health and Human Services, //. Accessed December 5, 2006
-
United States Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents - October 6, 2005. Available from htip://www.AIDSinfo.NIH.gov. Accessed December 5, 2006.
-
(2005)
Available from htip
-
-
-
12
-
-
34948851207
-
-
Abbott Laboratories. Kaletra (lopinavir/ritonavir) package insert. Abboit Park, IL; 2006
-
Abbott Laboratories. Kaletra (lopinavir/ritonavir) package insert. Abboit Park, IL; 2006.
-
-
-
-
13
-
-
34948857334
-
-
Abbott Laboratories. Norvir (ritonavir) package insert. Abboit Park, IL; 2006
-
Abbott Laboratories. Norvir (ritonavir) package insert. Abboit Park, IL; 2006.
-
-
-
-
14
-
-
34948882183
-
-
Agouron Pharmaceuticals INC. Rescriptor (delavirdine) package insert. La Jolla, CA; 2006
-
Agouron Pharmaceuticals INC. Rescriptor (delavirdine) package insert. La Jolla, CA; 2006.
-
-
-
-
15
-
-
34948836643
-
-
Agouron Pharmaceuticals INC. Viracept (nelfinavir) package insert. La Jolla, CA; 2006
-
Agouron Pharmaceuticals INC. Viracept (nelfinavir) package insert. La Jolla, CA; 2006.
-
-
-
-
16
-
-
34948881081
-
-
Boehringer Ingelheim GmbH. Aptivus (tipranavir) package insert. Ingelheim, Germany; 2006
-
Boehringer Ingelheim GmbH. Aptivus (tipranavir) package insert. Ingelheim, Germany; 2006.
-
-
-
-
17
-
-
34948848489
-
-
Boehringer Ingelheim GmbH. Viramune (nevirapine) package insert. Ingelheim, Germany; 2005
-
Boehringer Ingelheim GmbH. Viramune (nevirapine) package insert. Ingelheim, Germany; 2005.
-
-
-
-
18
-
-
34948866130
-
-
Bristol-Myers Squibb. Reyataz (atazanavir) package insert. Princeton, NJ; 2006
-
Bristol-Myers Squibb. Reyataz (atazanavir) package insert. Princeton, NJ; 2006.
-
-
-
-
19
-
-
34948893313
-
-
Bristol-Myers Squibb. Videx EC (didanosine EC) package insert. Princeton, NJ; 2006
-
Bristol-Myers Squibb. Videx EC (didanosine EC) package insert. Princeton, NJ; 2006.
-
-
-
-
20
-
-
34948873537
-
-
Bristol-Myers Squibb. Zerit (stavudine) package insert. Princeton, NJ; 2006
-
Bristol-Myers Squibb. Zerit (stavudine) package insert. Princeton, NJ; 2006.
-
-
-
-
21
-
-
34948907757
-
-
Gilead Sciences. Emtriva (emtricitabine) package insert. Foster City, CA; 2006
-
Gilead Sciences. Emtriva (emtricitabine) package insert. Foster City, CA; 2006.
-
-
-
-
22
-
-
34948820548
-
-
Gilead Sciences. Viread (lenofovir) package insert. Foster City, CA; 2006
-
Gilead Sciences. Viread (lenofovir) package insert. Foster City, CA; 2006.
-
-
-
-
23
-
-
34948882184
-
-
GlaxoSmithKline. Epivir (lamivudine) package insert. Research Triangle Park, NC; 2006
-
GlaxoSmithKline. Epivir (lamivudine) package insert. Research Triangle Park, NC; 2006.
-
-
-
-
24
-
-
34948900753
-
-
GlaxoSmithKline. Lexiva (fosamprenavir) package insert. Research Triangle Park, NC; 2006
-
GlaxoSmithKline. Lexiva (fosamprenavir) package insert. Research Triangle Park, NC; 2006.
-
-
-
-
25
-
-
34948910559
-
-
GlaxoSmithKline. Retrovir (zidovudine) package insert. Research Triangle Park, NC; 2006
-
GlaxoSmithKline. Retrovir (zidovudine) package insert. Research Triangle Park, NC; 2006.
-
-
-
-
26
-
-
34948898450
-
-
GlaxoSmithKline. Ziagen (abacavir) package insert. Research Triangle Park, NC; 2006
-
GlaxoSmithKline. Ziagen (abacavir) package insert. Research Triangle Park, NC; 2006.
-
-
-
-
27
-
-
34948872454
-
-
Merck & Co, Inc. Crixivan (indinavir) package insert. Whitehouse Station, NJ; 2006
-
Merck & Co, Inc. Crixivan (indinavir) package insert. Whitehouse Station, NJ; 2006.
-
-
-
-
28
-
-
34948835074
-
-
Roche Pharmaceuticals. Fuzeon (enfuvirtide) package insert. Nutley, NJ; 2006
-
Roche Pharmaceuticals. Fuzeon (enfuvirtide) package insert. Nutley, NJ; 2006.
-
-
-
-
29
-
-
34948859951
-
-
Roche Pharmaceuticals. Invirase (saquinavir mesylate) package insert. Nutley, NJ; 006
-
Roche Pharmaceuticals. Invirase (saquinavir mesylate) package insert. Nutley, NJ; 006.
-
-
-
-
30
-
-
0004301834
-
-
Internet database. Greenwood Village, CO
-
Micromedex Healthcare Series. Internet database. Greenwood Village, CO, 2007.
-
(2007)
Micromedex Healthcare Series
-
-
-
32
-
-
0032822545
-
Antiretroviral medication errors for patients with HIV infection
-
Purdy BD, Lesar TS. Antiretroviral medication errors for patients with HIV infection. AIDS Read 1999;9:414-19.
-
(1999)
AIDS Read
, vol.9
, pp. 414-419
-
-
Purdy, B.D.1
Lesar, T.S.2
-
33
-
-
33748663517
-
Antiretroviral medication errors among hospitalized patients with HIV infection
-
Rastegar DA, Knight AM, Monolakis JS. Antiretroviral medication errors among hospitalized patients with HIV infection. Clin Infect Dis 2006;43:933-8.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 933-938
-
-
Rastegar, D.A.1
Knight, A.M.2
Monolakis, J.S.3
|